U.S. flag An official website of the United States government
  1. Home
  2. Training and Continuing Education
  3. FDA Continuing Education Programs
  4. Topics in Public Health
  1. FDA Continuing Education Programs

Topics in Public Health

tablet webinarThe Topics in Public Health (TPH) Series is a complimentary educational series that targets public health professionals.

The series meets the need to provide educational offerings pertinent to public health professionals through exposure of topics that directly affect public health.

TPH presents offerings directly related to the Health and Human Services (HHS) Strategic Plan, HHS Secretary's Strategic Initiatives, topics relevant to the DHHS Operating Divisions, and/or other topics directly related to the advancement of public health.

Continuing Education (CE) Credit

CE credit is available for physicians, physician assistants, pharmacists, nurses, and certified public health professionals who attend our live webinars. Refer to the Activity Outline for complete CME, CPE, CNE, and CPH information. If CE credit is unavailable, it will be clearly noted.

Back to Top

Current Offering Information

When: March 15, 2024
Time: 2:00 - 3:00 pm EST
Topics in Public Health: Underrepresentation of American Indian and Alaska Natives in Clinical Research: Outlining Opportunities that May Exist for Participation at the NIH Clinical Center

CE credit approval: 1-hour for physicians, physician assistants, nurses, and pharmacists (see Activity Outline for more details)

Register here for webcast (public attendees and FDA staff)

Presented by: 

  • CAPT Julie Erb-Alvarez, MPH, CPH

Abstract: 

American Indian and Alaska Native people are historically underrepresented in clinical research, for understandable reasons. Inclusion of AI/AN people in clinical research is vital to ensure our understanding of treatment, disease causation, and prevention applies also to AI/AN populations. Clinical research is vital for translation of scientific observations and laboratory discoveries into new approaches to diagnose, treat and prevent diseases. The NIH intramural research program is housed in the NIH Clinical Center (CC) in Bethesda, Maryland, the nation's largest publicly funded hospital devoted entirely to clinical research. The NIH is well-known for conducting cutting edge, high-risk high-reward studies that have resulted in many clinical and medical innovations that are common practice today, and typically focuses on rare and severe diseases and conditions. People eligible for participating in any study at the NIH CC can do so at no cost, with all travel and accommodations typically covered by the NIH. The NIH is often referred to also as the National Institutes of Hope, as many patients who are cared for at the NIH CC have often exhausted all other treatments for sometimes life-threatening diseases, illnesses, and conditions.

Upcoming Webinars – Save the Date!

Registration information will be released via email. Sign up here!

Past Webinars

Date Topics in Public Health Speaker Name(s)
December 15, 2023 Addressing Psychological Trauma in the Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Community 
  • CDR Nicole Pascua, MPH, MSW, LICSW
  • LCDR Jennifer Weekes, PhD, LICSW, MPH, CHES, BCD
  • LT Kun-Yueh Hsieh, PhD, ABPP
April 21, 2023

The Changing Demographics of Youth Suicidal Behavior: The Facts, Figures, and Actions Needed (Presentation 1) Suicidality Among Sexual Minority Adults: Gender, Age, and Race/Ethnicity Differences (Presentation 2)

  • CAPT Lisa Colpe, USPHS (Ret.), PhD, MPH
  • Arielle H. Sheftall, PhD
March 17, 2023 Demonstrating Substitutability Between Generic and Brand Narrow Therapeutic Index Drug Products 
  • CDR Trang Tran, PharmD, MBA, BCPS 
  • LCDR Daniil Marchuk, PharmD, BCPA, PMP
January 20, 2023 Health Disparities among AAPI Populations: An Overview and Examples in Cancer Health
  • CAPT, U.S. PHS (retired) Graydon Yatabe, RD, MPH
  • LT Jin Qin, ScD, MS
December 2, 2022 Environmental Justice: Exploring Historic and Current Actions to Advance HealthEquity
  • CDR Candis Hunter, PhD, MPH, REHS
  • LT Janesa Licorish, MPH
October 21, 2022 Conversations in Equity Series: Race, Ethnicity, Data, and Equity 
  • RDML Richardae Araojo, PharmD
  • Aloka Chakravarty, PhD
  • Tamar Lasky, PhD
September 16, 2022 Advancing maternal health: series on maternal morbidity, mortality and clinical research
  • LCDR Miriam Dinatale, DO
  • Kimberly Sherman, MPH, MPP
August 19, 2022 Fact vs Fiction: Strategies to Identify and Limit the Spread of COVID-19 Misinformation
  • LCDR Kodilichi Echeozo, PharmD, MBA, BCPS, BCACP
  • CDR Valerie Marshall, MPH, PMP, GWCPM 
July 22, 2022 Managing Logistics and Roles for Treatment and Prevention of COVID-19
  • LCDR Abigail Petrulis, PharmD
June 3, 2022 Diagnosis & Management of Nonalcoholic Fatty Liver Disease in the Pediatric Patient
  • Leticia Hardy, MD
December 10, 2021

Healthy People 2030: Eliminating Health Disparities and Achieving Health Equity Among Asian American and Native American Pacific Islander Populations (AANAPI) 

  • CDR David Huang, PhD, MPH, CPH 
November 19, 2021 Native American/American Indian Cultural Awareness: The Impact of Historical and Intergenerational Trauma
  • Sonya Frazier, RN, BSN
October 22, 2021 Building Bridges of Trust with Diverse Communities
  • Jovonni Spinner, DrPH
September 17, 2021 How Racism and Discrimination Impact Latino/Hispanic Health
  • Eliseo Pérez-Stable, MD
March 19, 2021 Statin-associated autoimmune myopathy in eight American Indian patients: Lessons and Opportunities
  • Patrick Galdun, PharmD
  • Ryan Close, MD, MPH
  • Laura Close, DNP, FNP-BC
October 23, 2020 Youth Suicide Trends in the United States
  • Brandon Johnson, M.H.S
March 20, 2020 Clinical Relevance of Product Quality and Drug Manufacturing
  • LCDR Mahesh Ramanadham, PharmD, MBA
January 17, 2020 Sexually Transmitted Disease & Cervical Cancer Screening: What, When, & How
  • CDR Julia Shemek, WHNP-BC
December 13, 2019 President’s Emergency Plan for AIDS Relief (PEPFAR) – The Basics
  • CDR Tina Nhu, PharmD, RPh
Friday, November 15, 2019 The Challenge of Cybersecurity in Public Health
  • CDR Misty Rios, APRN, FNP-C, CCHP-MH
Friday, October 18, 2019 Community Health Care - “Extra-Clinical Care”: An Innovative and Systematized Approach to Healthcare Risk Assessments for the Homeless and the Underserved Populations
  • LCDR Kelly Fath, MSN, FNP-BC
Friday, July 19, 2019 Pills, Patches and Rings Oh My! How pharmacists can navigate the road to expand contraception care and STI screening
  • LCDR Thalia Vega, PharmD, BCACP
Friday, June 21, 2019 
The Opioid & Prescription Drug Crisis & Building Recovery-Ready Communities
  • Justin Riley, President & CEO, Young People in Recovery
  • Franklin Erickson, National Program Director, Young People in Recovery
Friday, March 22, 2019 
Electronic Nicotine Delivery Systems: An Overview
  • CDR Thomas Addison, PharmD, BCACP, NCPS
  • CDR Jing Li, PharmD, BCPS, cTTS
Friday, December 14, 2018 
Not Your Typical Disaster Response: An FDA View of the 2017 Hurricane Season
  • CAPT Catherine Chew, PharmD, BCGP
  • CDR Emily Thakur, RPh
  • CDR Kelly Ngan, PharmD, MPH
Friday, November 16, 2018  Arresting Tuberculosis (TB): The Challenges of TB Management in an Immigrant Detention Setting 
  • CAPT Diana Elson, DRPH, MA
  • CDR Edie Lederman, MD, MPH, FACP, FIDSA
  • CDR Geri Tagliaferri, RN, BSN, MPH
  • Nicole Boardman, MPH
Friday, October 19,2018 Advancing Public Health Through the Project ECHO Model
  • Aimee Young,, PharmD, BCPS, CPE
  • Sarah Freeman, PharmD
  • David Espey, MD,
  • Shawna Williams, MPH,CHES
  • Karla Thornton, MD, MPH
  • Christopher Piromalli, MPH, DO
Friday, September 21, 2018  Veterinary Laboratory Investigation and Response Network
  • Jennifer L.A. Jones, DVM FDA 
Friday, July 20, 2018

Current Utilization and Payment Trends in Medication Assisted Treatment (MAT) Therapies for Opioid Misuse and Overdose

  • CDR Matthew Febbo, MBA, RPh
  • Jean Mackey Bennett, PHD, MSM, MSN, RN
  • Hooshang Shanehsaz, RPH

Back to Top

 
Back to Top